Chr. Hansen and Novozymes merge in largest Danish deal on record
date:Dec 14, 2022
ominique Reiniche, chair of the Chr. Hansen Board of Directors.

The combined business offers a great opportunity to pursue attractive synergies by creating new solutions for the benefit of our customers and consumers, and will create value for all our shareholders as well as for society, she concludes.
7/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/20 22:31